24236-389 : Combivir (Lamivudine 150 mg)


NDC24236-389
Labeler: Remedyrepack Inc.
Product Type: Human Prescription Drug
Drug Name:  Combivir
Dosage Form: Oral Tablet, Film Coated
Application #: NDA020857
Rev. Date: 


Appearance:


Markings: GXFC3
Shapes:  Oval
Colors:  White
Size (mm): 17
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

GXFC3: (49702-202) Combivir (Lamivudine 150 mg) by Remedyrepack Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 24236-389-12: 8 TABLET, FILM COATED IN 1 BLISTER PACK (24236‑389‑12)
  • 24236-389-21: 120 TABLET, FILM COATED IN 1 CANISTER (24236‑389‑21)

Active Ingredients:

  • Lamivudine

Dosage Strength:

  • 150 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Polysorbate 80
  • Polyethylene Glycols
  • Sodium Starch Glycolate Type a Potato
  • Colloidal Silicon Dioxide
  • Hypromelloses
  • Magnesium Stearate
  • Titanium Dioxide
  • Colloidal Silicon Dioxide
  • Hypromelloses
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycols
  • Polysorbate 80
  • Sodium Starch Glycolate Type a Potato
  • Titanium Dioxide

Pharmaceutical Classes:

  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 49349-683 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Remedyrepack Inc.
  • 0173-0595 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Glaxosmithkline LLC
  • 11819-359 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Hhs/Program Support Center/Supply Service Center
  • 16590-061 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Stat Rx USA
  • 21695-846 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Rebel Distributors Corp
  • 49702-202 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Viiv Healthcare Company
  • 50090-0610 Combivir Oral Tablet, Film Coated by A-s Medication Solutions
  • 52959-546 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by H.j. Harkins Company, Inc.
  • 53808-0895 Combivir Oral Tablet, Film Coated by State of Florida Doh Central Pharmacy
  • 54569-4524 Combivir Oral Tablet, Film Coated by A-s Medication Solutions
  • 55289-389 Combivir (Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Pd-rx Pharmaceuticals, Inc.
  • 63379-025 Combivir Oral Tablet, Film Coated by Glaxo Operations Uk Ltd

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 24236-389 QR Code

< Prev: 24236-387Next: 24236-403 >

Related Discussions:

During my Lamivudine/Zidovudine and Efarenz medication, take ginseng?
During my Lamivudine/Zidovudine and Efarenz medication as a HIV patient take Ginseng and other kind of natural supliment...
Cannot get Combivir
I am currently working in SE Asia and may have been exposed to HIV. I cannot get combivir but did find in pill form the ...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA